Previous Close | 37.90 |
Open | 37.69 |
Bid | 37.05 x 100 |
Ask | 37.25 x 100 |
Day's Range | 37.08 - 38.15 |
52 Week Range | 3.16 - 53.82 |
Volume | |
Avg. Volume | 301,827 |
Market Cap | 1.206B |
Beta (5Y Monthly) | -1.54 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.36 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 64.33 |
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Just because a business does not make any money, does not mean that the stock will go down. For example, Soleno...